Stock Fundamentals

Company Information

Company Name
Edgewise Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US28036F1057
CIK: 0001710072
CUSIP: 28036F105
Currency: USD
Full Time Employees: 154
Phone: 720 262 7002
Fiscal Year End: December
IPO Date: Mar 26, 2021
Description:

Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, sevasemten, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders that is in Phase I clinical trials; and EDG-15400, a novel small molecule for the treatment of heart failure with preserved ejection fraction. In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. The company was incorporated in 2017 and is headquartered in Boulder, Colorado.

Address:

1715 38th Street, Boulder, CO, United States, 80301

Directors & Officers

Name Title Year Born
Dr. Peter A. Thompson FACP, M.D. Co-Founder & Independent Chairman 1960
Dr. Kevin Koch Ph.D. President, CEO & Director 1960
Dr. Badreddin Edris Ph.D. Co-Founder & Independent Director 1987
Dr. Alan J. Russell Ph.D. Co-Founder, Chief Scientific Officer & Director 1970
Mr. Michael P. Nofi Chief Financial Officer 1971
Dr. Behrad Derakhshan Ph.D. Chief Operating Officer 1980
Dr. Joanne M. Donovan M.D., Ph.D. Chief Medical Officer 1957
Mr. John R. Moore J.D. General Counsel 1964

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 01, 2026 Joanne M Donovan N/A Sale 28.66K $32.31 $926.07K
Jan 21, 2026 Badreddin Edris N/A Sale 115.47K $29.44 $3.40M
Nov 12, 2025 Alan J Russell N/A Sale 100.00K $21.12 $2.11M
Nov 11, 2025 Jonathan C Fox N/A Purchase 10.70K $18.64 $199.45K
Aug 26, 2025 Alan J Russell N/A Sale 100.00K $14.60 $1.46M
Aug 12, 2025 Alan J Russell N/A Sale 1.91K $13.39 $25.53K
Aug 12, 2025 Joanne M Donovan N/A Sale 2.86K $13.39 $38.32K
Aug 12, 2025 John R Moore N/A Sale 2.10K $13.39 $28.09K
Aug 12, 2025 Kevin Koch N/A Sale 7.97K $13.39 $106.75K
Aug 12, 2025 R Michael Carruthers N/A Sale 1.43K $13.39 $19.12K
May 02, 2025 Alan J Russell N/A Sale 1.55K $16.45 $25.51K
May 02, 2025 Joanne M Donovan N/A Sale 5.19K $16.45 $85.33K
May 02, 2025 John R Moore N/A Sale 1.93K $16.45 $31.75K
May 02, 2025 Kevin Koch N/A Sale 4.28K $16.45 $70.34K
May 02, 2025 R Michael Carruthers N/A Sale 1.31K $16.45 $21.62K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Orbimed Advisors, LLC 15.52M Mar 31, 2026 14.42% $9.69 0.00%
RA Capital Management, LLC 10.43M Mar 31, 2026 9.69% $3.48 0.00%
Paradigm Biocapital Advisors LP 7.37M Mar 31, 2026 6.85% $4.74 12.59%
Baker Bros Advisors LP 6.58M Mar 31, 2026 6.11% $1.19 0.00%
BlackRock Inc 6.47M Mar 31, 2026 6.02% $0.00 -2.38%
HHG PLC 5.92M Mar 31, 2026 5.50% $0.09 29.53%
Novo A/S 5.35M Mar 31, 2026 4.97% $13.65 0.00%
Vanguard Group Inc 4.87M Dec 31, 2025 4.53% $0.00 1.41%
Driehaus Capital Management LLC 4.48M Mar 31, 2026 4.16% $1.04 6.84%
Siren, L.L.C. 4.43M Mar 31, 2026 4.12% $3.87 -2.20%
Perceptive Advisors LLC 4.42M Mar 31, 2026 4.11% $2.72 -0.76%
Vanguard Capital Management, LLC 3.79M Mar 31, 2026 3.52% $0.00 0.00%
Cormorant Asset Management, LLC 3.26M Mar 31, 2026 3.03% $5.16 -0.76%
BRAIDWELL LP 2.35M Mar 31, 2026 2.18% $2.47 -54.95%
Morgan Stanley - Brokerage Accounts 2.25M Mar 31, 2026 2.09% $0.00 -22.84%
Geode Capital Management, LLC 1.79M Mar 31, 2026 1.66% $0.00 2.50%
AllianceBernstein L.P. 1.72M Mar 31, 2026 1.60% $0.01 66.21%
State Street Corp 1.72M Mar 31, 2026 1.60% $0.00 -0.03%
MPM Oncology Impact Management LP 1.66M Mar 31, 2026 1.54% $4.04 0.33%
Integral Health Asset Management, LLC 1.60M Mar 31, 2026 1.49% $2.41 6.67%

Shares Statistics

Shares Outstanding: 107.59M
Shares Float: 67.12M
% Insiders: 45.30%
% Institutions: 11,396.70%
Short % Float: 14.35%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 2.90M 2.69% ▲ 1.19% Apr 30, 2026
2 BB Biotech AG Ord 2.78M 2.58% ▲ 0.00% Sep 30, 2025
3 Strategic Advisers Fidelity US TtlStk 1.70M 1.58% ▲ 0.00% Apr 30, 2026
4 iShares Russell 2000 ETF 1.62M 1.50% ▲ 0.93% May 29, 2026
5 American Century U.S. Small Cap Growth 856.21K 0.80% ▼ 1.96% Mar 31, 2026
6 American Century Small Cap Growth Inv 856.21K 0.80% ▼ 1.96% Mar 31, 2026
7 Vanguard Institutional Extnd Mkt Idx Tr 836.47K 0.78% ▲ 1.19% Apr 30, 2026
8 Victory Pioneer Select Mid Cap Growth A 723.18K 0.67% ▲ 8.56% Mar 31, 2026
9 Fidelity Select Biotechnology 699.43K 0.65% ▼ 12.11% Apr 30, 2026
10 Janus Henderson Hrzn Biotec E2 USD 665.52K 0.62% ▲ 15.05% Mar 31, 2026

Valuation Metrics

Enterprise Value: $3.25B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $3.75B
EBITDA: $-197.45M
Book Value: $4.59
Earnings/Share: $-1.66
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -25.64%
ROE (TTM): -38.14%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 19.85x 0.00x 0.05x N/A -0.01x
2024-12-31 19.93x 0.00x 0.06x N/A -0.01x
2023-12-31 19.50x 0.00x 0.06x N/A -0.01x
2022-12-31 21.53x 0.00x 0.06x -5.50x -0.03x
2021-12-31 26.97x 0.00x 0.04x -158.88x 0.00x
2020-12-31 29.86x 0.00x 1.25x -249.16x 0.00x
2019-12-31 21.24x 0.00x 1.69x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about EWTX.US!